Heart Gross Profit from 2010 to 2024

HSCSW Stock

USD 0.03 0.00 0.00%

Heart Test Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to 8,643 in 2024. Gross Profit is the profit Heart Test Laboratories makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

12.5 K

Current Value

8.6 K

Quarterly Volatility

5 K

Credit Downgrade

Yuan Drop

Covid

Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Latest Heart Test's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Heart Test Laboratories over the last few years. Gross profit is a required income statement account that reflects total revenue of Heart Test Laboratories minus its cost of goods sold. It is profit before Heart Test operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Heart Test's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Heart Gross Profit Regression Statistics

	Arithmetic Mean	14,811
	Geometric Mean	13,340
	Coefficient Of Variation	33.88
	Mean Deviation	3,899
	Median	17,722
	Standard Deviation	5,018
	Sample Variance	25.2M
	Range	15.4K
	R-Value	(0.72)
	Mean Square Error	13.2M
	R-Squared	0.51
	Significance	0
	Slope	(803.28)
	Total Sum of Squares	352.6M

Heart Gross Profit History

	2024	8642.72
	2023	12.5 K
	2022	2354.0
	2021	6483.0
	2020	14.9 K

Other Fundumenentals of Heart Test Laboratories

Gross Profit Margin

Heart Test Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Good Will	Intangible Assets
Total Assets		0.85	0.68	-0.83	-0.93	0.37	-0.07	0.99	0.18	0.99	0.22	1.0	-0.45	0.96	0.19	-0.43	0.94	-0.94
Total Stockholder Equity	0.85		0.25	-1.0	-0.65	-0.09	-0.58	0.9	-0.36	0.9	-0.3	0.83	-0.43	0.95	-0.33	-0.42	0.81	-0.81
Current Deferred Revenue	0.68	0.25		-0.27	-0.88	0.85	0.48	0.63	0.67	0.58	0.67	0.71	0.08	0.5	0.62	0.09	0.64	-0.53
Net Debt	-0.83	-1.0	-0.27		0.65	0.07	0.61	-0.9	0.39	-0.88	0.32	-0.81	0.36	-0.94	0.36	0.35	-0.8	0.78
Retained Earnings	-0.93	-0.65	-0.88	0.65		-0.66	-0.14	-0.91	-0.42	-0.87	-0.42	-0.94	0.15	-0.83	-0.38	0.13	-0.81	0.85
Accounts Payable	0.37	-0.09	0.85	0.07	-0.66		0.58	0.3	0.81	0.23	0.83	0.4	0.31	0.13	0.8	0.32	0.22	-0.32
Long Term Debt	-0.07	-0.58	0.48	0.61	-0.14	0.58		-0.2	0.92	-0.16	0.84	-0.04	-0.02	-0.29	0.85	-0.02	-0.07	0.07
Net Receivables	0.99	0.9	0.63	-0.9	-0.91	0.3	-0.2		0.05	0.99	0.09	0.98	-0.39	0.98	0.06	-0.37	0.92	-0.93
Total Liab	0.18	-0.36	0.67	0.39	-0.42	0.81	0.92	0.05		0.07	0.94	0.21	0.0	-0.07	0.95	0.0	0.08	-0.21
Net Invested Capital	0.99	0.9	0.58	-0.88	-0.87	0.23	-0.16	0.99	0.07		0.11	0.98	-0.52	0.99	0.08	-0.51	0.94	-0.95
Short Long Term Debt	0.22	-0.3	0.67	0.32	-0.42	0.83	0.84	0.09	0.94	0.11		0.25	-0.09	-0.04	1.0	-0.08	0.17	-0.22
Total Current Assets	1.0	0.83	0.71	-0.81	-0.94	0.4	-0.04	0.98	0.21	0.98	0.25		-0.44	0.95	0.22	-0.42	0.93	-0.94
Capital Stock	-0.45	-0.43	0.08	0.36	0.15	0.31	-0.02	-0.39	0.0	-0.52	-0.09	-0.44		-0.47	-0.11	1.0	-0.53	0.53
Net Working Capital	0.96	0.95	0.5	-0.94	-0.83	0.13	-0.29	0.98	-0.07	0.99	-0.04	0.95	-0.47		-0.07	-0.45	0.91	-0.92
Short Term Debt	0.19	-0.33	0.62	0.36	-0.38	0.8	0.85	0.06	0.95	0.08	1.0	0.22	-0.11	-0.07		-0.11	0.13	-0.21
Common Stock	-0.43	-0.42	0.09	0.35	0.13	0.32	-0.02	-0.37	0.0	-0.51	-0.08	-0.42	1.0	-0.45	-0.11		-0.51	0.51
Good Will	0.94	0.81	0.64	-0.8	-0.81	0.22	-0.07	0.92	0.08	0.94	0.17	0.93	-0.53	0.91	0.13	-0.51		-0.8
Intangible Assets	-0.94	-0.81	-0.53	0.78	0.85	-0.32	0.07	-0.93	-0.21	-0.95	-0.22	-0.94	0.53	-0.92	-0.21	0.51	-0.8

Click cells to compare fundamentals

About Heart Test Financial Statements

Heart Test investors use historical fundamental indicators, such as Heart Test's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heart Test. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	12.5 K	8.6 K
Gross Profit Margin	0.67	0.39

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC